Medico Remedies Share Price

NSE
MEDICO •
BUY
The current prices are delayed, login or Open Demat Account for live prices.
Medico Remedies Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Medico Remedies Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
31.19% Fall from 52W High
-17.4
Dividend yield 1yr %
0

Medico Remedies shareholding Pattern

Promoter
63.8%
Foreign Institutions
0.1%
Public
36.1%
Promoter
66.8%
Foreign Institutions
0.4%
Domestic Institutions
0.8%
Public
32%
Promoter
73.3%
Foreign Institutions
0.2%
Domestic Institutions
1%
Public
25.5%
Promoter
73.3%
Foreign Institutions
0.2%
Domestic Institutions
1%
Public
25.5%
Promoter
73.3%
Foreign Institutions
0.3%
Domestic Institutions
0.7%
Public
25.6%
Promoter
73.3%
Foreign Institutions
1.3%
Public
25.4%

Medico Remedies Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
8
5Day EMA
54.20
10Day EMA
54.30
12Day EMA
54.40
20Day EMA
54.80
26Day EMA
55.10
50Day EMA
56.20
100Day EMA
56.60
200Day EMA
56.10
5Day SMA
54.40
10Day SMA
53.80
20Day SMA
55.60
30Day SMA
55.90
50Day SMA
54.90
100Day SMA
59.70
150Day SMA
56.80
200Day SMA
53.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
441771 Rs
952293 Rs
Week Rs
378567 Rs
737202 Rs
Month Rs
322690 Rs
715849 Rs
Resistance & Support
54.28
Pivot
Resistance
First Resistance
55.70
Second Resistance
56.47
Third Resistance
57.89
Support
First Support
53.51
Second support
52.09
Third Support
51.32
Relative Strength Index
49.50
Money Flow Index
45.50
MACD
-0.66
MACD Signal
-0.58
Average True Range
3.55
Average Directional Index
17.73
Rate of Change (21)
-6.99
Rate of Change (125)
-9.85

Medico Remedies Latest News

15 MAY 2025 | Thursday

Medico Remedies Ltd - 540937 - Intimation For Commencement Of Work For New Factory Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations')

10 MAY 2025 | Saturday

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication

08 MAY 2025 | Thursday

Medico Remedies Ltd - 540937 - Appointment Of Secretarial Auditor & Approval Of Director''s Report Alongwith Annexures

View More

Medico Remedies Company background

Founded in: 1994
Managing director: Harshit Mehta
Medico Remedies Limited was incorporated as a Private Limited Company with the name Medico Remedies Private Limited on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on antiinfective, BetaLactums, cephalosporins, antimalarial, antiretroviral, antiulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, AntiEpileptics, combination drug kits, syrups and cream gel for various therapeutic segments.The Company is ISO 9001:2015 certified for its management system for the manufacture and marketing of pharmaceutical products. It also obtained a WHOGMP accreditation for the manufacture of its products from the World Health Organisation and has also been certified by Government Recognised Star Exports, Pharmacy and Poison Board, NAFDAC and National Drug Authority, Uganda.The Company began its operations in 1994 with manufacturing and servicing of diuretics, antimalarials, NSAIDS tablets, antireterovirals, antiulcer drugs and antiacids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in year 1999 2002, Company has a manufacturing facility for the manufacture of its products located in the State of Maharashtra at Palghar.. The plant is divided into two units, i.e. general formulations unit and betalactam unit the beta lactam unit is further divided into two segments Penicillin and Cephalosporins.The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.In 201819, the Company purchased adjoining manufacturing unit with existing factory at Palghar. In January 2018, the Company came up with a Public Issue of 10,99,200 Equity Shares by raising equity capital amounting to Rs 10.99 Crores.
Read More

Medico Remedies FAQs

Medico Remedies share price is ₹55.02 in NSE and ₹55 in BSE as on 16/5/2025.

Medico Remedies share price in the past 1-year return was 35.79. The Medico Remedies share hit a 1-year low of Rs. 34.8 and a 1-year high of Rs. 79.83.

The market cap of Medico Remedies is Rs. 455.83 Cr. as of 16/5/2025.

The PE ratios of Medico Remedies is 45.01 as of 16/5/2025.

The PB ratios of Medico Remedies is 7.29 as of 16/5/2025

You can easily buy Medico Remedies shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Medico Remedies stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -